Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-04-02
2010-06-22
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S313000
Reexamination Certificate
active
07741268
ABSTRACT:
The invention relates to the field of pharmaceutical formulations of follicle-stimulating hormone (FSH), luteinising hormone (LH), and mixtures of FSH and luteinising hormone (LH), and to methods of producing such formulations. The invention provides a liquid or freeze-dried formulation of FSH, or LH, or FSH and LH comprising a surfactant selected from Pluronic® F77, Pluronic F87, Pluronic F88 and Pluronic F68.
REFERENCES:
patent: 4496537 (1985-01-01), Kwan
patent: 4589402 (1986-05-01), Hodgen et al.
patent: 4659696 (1987-04-01), Hirai et al.
patent: 4670419 (1987-06-01), Uda et al.
patent: 4746508 (1988-05-01), Carey et al.
patent: 4839341 (1989-06-01), Massey
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 5087615 (1992-02-01), Chappel et al.
patent: 5128453 (1992-07-01), Arpaia et al.
patent: 5162306 (1992-11-01), Donaldson
patent: 5270057 (1993-12-01), de Meere et al.
patent: 5356876 (1994-10-01), Espey
patent: 5374620 (1994-12-01), Clark et al.
patent: 5384132 (1995-01-01), De Meere et al.
patent: 5508261 (1996-04-01), Moyle et al.
patent: 5580856 (1996-12-01), Prestrelski et al.
patent: 5639640 (1997-06-01), Reddy et al.
patent: 5650390 (1997-07-01), Samaritani et al.
patent: 5661125 (1997-08-01), Strickland
patent: 5681822 (1997-10-01), Bornstein et al.
patent: 5733572 (1998-03-01), Unger et al.
patent: 5767067 (1998-06-01), Arpaia et al.
patent: 5811096 (1998-09-01), Aleman et al.
patent: 5889110 (1999-03-01), Hutchinson et al.
patent: 5929028 (1999-07-01), Skrabanja et al.
patent: 5945187 (1999-08-01), Buch-Rasmussen et al.
patent: 6066620 (2000-05-01), McGregor et al.
patent: 6113947 (2000-09-01), Cleland et al.
patent: 6136784 (2000-10-01), L'Italien et al.
patent: 6238890 (2001-05-01), Boime et al.
patent: 6267958 (2001-07-01), Andya et al.
patent: 6346274 (2002-02-01), Koll et al.
patent: 6440930 (2002-08-01), Rinella, Jr.
patent: 6524557 (2003-02-01), Backstrom et al.
patent: 6541606 (2003-04-01), Margolin et al.
patent: 6573237 (2003-06-01), Rinella, Jr.
patent: 2002/0165146 (2002-11-01), Hoffman et al.
patent: 2003/0072803 (2003-04-01), Goldenberg et al.
patent: 2004/0028733 (2004-02-01), Tracy et al.
patent: 1340132 (1998-11-01), None
patent: 41 17 078 (1882-11-01), None
patent: 0 318 081 (1989-05-01), None
patent: 0 448 146 (1991-09-01), None
patent: 0 652 766 (1993-07-01), None
patent: 0 603 159 (1994-06-01), None
patent: 0 853 945 (1998-07-01), None
patent: 0 920 873 (1998-12-01), None
patent: 0 891 774 (1999-01-01), None
patent: 0 668 073 (1999-04-01), None
patent: 1 191 099 (1999-06-01), None
patent: 0 736 303 (1999-08-01), None
patent: 0 974 359 (2000-01-01), None
patent: 0974359 (2000-01-01), None
patent: 2 782 455 (2000-02-01), None
patent: 2782455 (2000-02-01), None
patent: 839300 (1958-08-01), None
patent: 1 065 127 (1967-04-01), None
patent: 1065127 (1967-04-01), None
patent: WO 92/21332 (1992-12-01), None
patent: WO 92/22568 (1992-12-01), None
patent: WO 93/11788 (1993-06-01), None
patent: WO 94/03198 (1994-02-01), None
patent: WO 97/04801 (1997-02-01), None
patent: WO 97/17087 (1997-05-01), None
patent: WO 98/30592 (1998-07-01), None
patent: 99 21534 (1999-05-01), None
patent: WO 99/21534 (1999-05-01), None
U.S. Appl. No. 10/561,529, filed Dec. 20, 2005, Samaritani et al.
Wenzel et al. “Pluronic F127 gel formulations of Deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle”, Journal of Controlled Release, vol. 85, pp. 51-59 2002.
Newman et al. “Use of Nonionic Block Copolymers in Vaccines and Therapeutics”, Critical Reviews in Therapeutic Drug Carrier Systems, vol. 15, No. 2, pp. 89-140 1998.
Burgues et al. “Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism”, Human Reproduction, vol. 12, No. 5, pp. 980-986 1997.
Shome et al. “A Reevaluation of the Amino Acid Sequence of Human Follitropin beta-Subunit”, Journal of Protein Chemistry, vol. 7, No. 4, pp. 325-339 1988.
Keutmann et al. “Structure of Human Luteinizing Hormone Beta Subunit: Evidence for a Related Carboxyl-Terminal Sequence Among Certain Peptide Hormones”, Biochemical and Biophysical Research Communications, vol. 90, No. 3, pp. 842-848 1979.
Talmadge et al. “Evolution of the genes for the beta subunits of human chorionic gonadotropin and luteinizing hormone”, Nature, vol. 307, pp. 37-40 1984.
Fiddes et al. “Structure, Expression, and Evolution of the Genes for the Human Glycoprotein Hormones”, Recent Progress in Hormone Research, vol. 40, pp. 43-78.
Klein et al. “Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey”, Fertility and Sterility, vol. 77, No. 6, pp. 1248-1255 2002.
Fiddes et al. “The Gene Encoding the Common Alpha Subunit of the Four Human Glycoprotein Hormones”, Journal of Molecular and Applied Genetics, vol. 1, pp. 3-18 1981.
Maurer et al. “Isolation and Nucleotide Sequence Analysis of a Cloned cDNA Encoding the beta-Subunit of Bovine Follicle-Stimulating Hormone”, DNA, vol. 5, No. 5, pp. 363-369 1986.
Watkins et al. “DNA Sequence and Regional Assignment of the Human Follicle-Stimulating Hormone beta-Subunit Gene to the Short Arm of Human Chromosome 11”, DNA, vol. 6, No. 3, pp. 205-212 1987.
Hirai et al. “The gene for the beta subunit of porcine FSH: absence of consensus oestrogen-responsive element and presence of retroposons”, Journal of Molecular Endocrinology, vol. 5, pp. 147-158 1990.
Maurer. “Molecular Cloning and Nucleotide Sequence Analysis of Complementary Deoxyribonucleic Acid for the beta-Subunit of Rat Follicle Stimulating Hormone”, Molecular Endocrinology, vol. 1, pp. 717-723 1987.
Guzman et al. “The Gene Encoding Ovine Follicle-Stimulating Hormone beta: Isolation, Characterization, and Comparison to a Related Ovine Genomic Sequence”, DNA and Cell Biology, vol. 10, No. 8, pp. 593-601 1991.
Kumar et al. “Cloning of the mouse gonadotropin beta-subunit-encoding genes, II. Structure of the luteinizing hormone beta-subunit-encoding genes”, Gene, vol. 166, pp. 335-336 1995.
Kumar et al. “Cloning of the mouse gonadotropin beta-subunit-encoding genes, I. Structure of the follicle-stimulating hormone beta-subunit-encoding gene”, Gene, vol. 166, pp. 333-334 1995.
Steelman et al. “Assay of the Follicle Stimulating Hormone Based on the Augmentation with Human Chorionic Gonadotropin”, Endocrinology, vol. 53, pp. 604-616 1953.
Van Hell et al. “Effects of Human Menopausal Gonadotrophin Preparations in Different Bioassay Methods”, Acta Endocrinologica, vol. 47, pp. 409-418 1964.
Akers Michael J., “Considerations in selecting antimicrobial preservative agents for parenteral product development”, Pharmaceutical Technology, May 1984, pp. 36-46.
Akers, Michael J., “Excipient—Drug Interactions in Parenteral Formulations”, Journal of Pharmaceutical Sciences, Nov. 2002, vol. 91, No. 11, pp. 2283-2300.
Amir, Syed M. et al., “Phenol, A Potent Stimulator of Adenylate Cyclase in Human Thyroid Membranes”, Endocrine Research Communications, 8(2):83-95, 1981.
A.P.L.® Injection 5 000 IU and Injection 10 000 IU, http://home.intekom.com/pharm/akromed/apl-inj.html, Dec. 12, 2002, pp. 1-2.
A.P.L.® (chorionic gonadotropin for injection, USP), for Intramuscular Injection Only, Physicians' Desk Reference, 51stEdition, p. 2805.
A.P.L.®, Physicians' Desk Reference, 12thEdition, p. 625.
A.P.L.®, Physicians' Desk Reference, 19thEdition, p. 537.
A.P.L.®, Physicians' Desk Reference, 34thEdition, p. 592.
Arzneiformenlehre, Paul Heinz List, Wissenschaftliche Verlagsgellschaft mbH, Stuttgart, 4th Edition, 1985, pp. 402-407.
Asellacrin®, Physicians' Desk Reference, 34thEdition, pp. 16
Donati Piergiorgio
Samaritani Fabrizio
Ares Trading S.A.
Gupta Anish
Woodard Emhardt Moriarty McNett & Henry
LandOfFree
Liquid pharmaceutical formulations of FSH and LH together... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liquid pharmaceutical formulations of FSH and LH together..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid pharmaceutical formulations of FSH and LH together... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4188666